Sign in
Knowstox

Fundamentals snapshot

Milestone Scientific Inc.

MLSS · ASE · Healthcare · Medical Instruments & Supplies

Current price

$0.35

52-week range

$0.22 - $0.58

Market cap

$31.53M

One-glance verdict

Overvalued

$0.09 our estimate vs market $0.35

Wall Street consensus: $1.25 (1,223.5% higher than our fair-value estimate)

Balance sheet

Healthy

-348.20x Concerning

Net cash $1.45M. Interest coverage shows how many times profit covers the interest bill.

What this company does

Milestone Scientific Inc.

Milestone Scientific sells special medical and dental devices, like a computer-controlled system for painless injections used by dentists and doctors. Most of their money comes from selling these innovative devices, which is important because it shows their technology is being adopted by healthcare professionals looking for better ways to deliver treatments. They are focused on making the injection process smoother and less uncomfortable for patients.

Price history

How the share price has moved

—
Loading price history…

Earnings history

Last 8 quarters — what happened

Click any quarter to read the call summary and what the numbers say.

Free cash flow by quarter (oldest to newest)
FY2024 Q3 $-980.51K FY2024 Q4 $-1.52M FY2025 Q1 $-1.01M FY2025 Q2 $-1.77M FY2025 Q3 $75.54K FY2025 Q4 $-229.25K FY2026 Q1 $85.21K FY2026 Q2 $-589.27K
Revenue —
Net income $-1.06M
Diluted EPS -0.01
Operating cash flow $-585.13K
Free cash flow $-589.27K
Revenue —
Net income $-839.85K
Diluted EPS -0.01
Operating cash flow $86.84K
Free cash flow $85.21K
Revenue —
Net income $-1.09M
Diluted EPS -0.02
Operating cash flow $-226.13K
Free cash flow $-229.25K
Revenue —
Net income $-1.15M
Diluted EPS -0.01
Operating cash flow $81.78K
Free cash flow $75.54K
Revenue —
Net income $-1.48M
Diluted EPS -0.02
Operating cash flow $-1.76M
Free cash flow $-1.77M
Revenue —
Net income $-1.99M
Diluted EPS -0.02
Operating cash flow $-1.01M
Free cash flow $-1.01M
Revenue —
Net income $-2.04M
Diluted EPS -0.06
Operating cash flow $-1.51M
Free cash flow $-1.52M
Revenue —
Net income $-1.46M
Diluted EPS -0.02
Operating cash flow $-973.91K
Free cash flow $-980.51K

Is it cheap or expensive?

Fair value $0.09 vs current price $0.35

Wall Street consensus is the average analyst price target: $1.25 (1,223.5% higher than our fair-value estimate).

Our most-likely fair value is $0.09 a share — about 72.9% below today's price of $0.35, so the stock currently looks expensive (overvalued).

overvalued

We estimate the cash this business should generate over the next 10 years and beyond, then convert it to today's money for a fair value per share, in its trading currency. Cautious, middle and optimistic growth cases give a range. Not for banks/insurers.

Base

Growth 8.0% · Discount 8.7% · Terminal 3.0%

$0.09

Bear

Growth 3.0% · Discount 8.7% · Terminal 3.0%

$0.07

Bull

Growth 15.0% · Discount 8.7% · Terminal 3.0%

$0.13

Is it drowning in debt?

Healthy

Net cash $1.5M - more cash than debt. Interest coverage -348.2x.

Net debt $-1.45M
Interest coverage -348.20x

Milestone Scientific Inc. is healthier than 0 of 1 peers on balance-sheet leverage.

Healthy
Worse cushion Baseline Better cushion
MLSS BASELINE Milestone Scientific Inc.

Total debt $615.70K Interest coverage -348.20x This is the baseline the peer rows are being compared against.

-348.20x

What you should know

The case for and against MLSS

2 Rewards 1 Risk

Rewards

  • Revenue grew 7.6% last year.
  • Free cash flow was positive in 1/10 years.

Risks

  • Return on equity was -121.7% last year — the company lost money on shareholders' equity.

The numbers

All the key metrics, grouped by purpose

Tap any ? icon to learn what it means.

Valuation

How expensive the stock looks

P/E (TTM)
—
Forward P/E
-9.94x
P/B
8.92x
P/S
3.35x
EV/EBITDA
-7.31x
PEG ratio
—

Profitability

How much profit each dollar creates

Gross margin
70.2%
Operating margin
-37.4%
Net margin
-44.0%
ROE
-121.7%
ROA
-31.3%

Health

Liquidity and balance-sheet strength

Debt / equity
0.18x
Current ratio
1.85x
Quick ratio
0.71x
Total debt
$615.70K
Total cash
$2.07M

Growth

How the business has been compounding

Revenue TTM
$11.28M
Revenue 5Y CAGR
3.0%
EPS TTM
-0.04
EPS 5Y CAGR
—

Cash flow

How much cash the business throws off

Operating CF TTM
$-642.64K
Free CF TTM
$-2.93M
FCF margin
-26.0%

Dividend

Shareholder payout

Yield
0.0%
Payout ratio
0.0%
Last ex-div date
—